Application no. and date | 18160237.6 (espacenet) (Federated) (European Patent Register), 20140314 | Patent/reg. no. and date | DK/EP 3388834, 20200415 | Publication date | 20181017 | Priority no. and date | US 201361789375 P, 20130315 | EP pub. no. and date |
EP 3388834 20181017 | Effective date | | Applicant/owner | Translate Bio, Inc., 29 Hartwell Avenue
Lexington, MA 02421, US | Applicant ref. no. | P72664DK01 | Inventor | HEARTLEIN, Michael, C/o Shire Human Genetic Therapies Inc. 300 Shire Way
Lexington, MA 02421, US, DEROSA, Frank, C/o Shire Human Genetic Therapies Inc. 300 Shire Way
Lexington, MA 02421, US, SMITH, Lianne, C/o Shire Human Genetic Therapies Inc. 300 Shire Way
Lexington, MA 02421, US, Guild, Braydon Charles, 109 Riverdale Road
Concord, MA 01742, US | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 31/7105 (2006.01) , A61K 48/00 (2006.01) , A61K 9/00 (2006.01) , A61K 9/127 (2006.01) | Title | SYNERGISTISK FORBEDRING AF LEVERING AF NUKLEINSYRER VIA BLANDEDE FORMULERINGER | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|